Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$238,293.00
May 1, 2023
For-profit organization
Potency Assay Development
1007347
MicroSintesis is developing a Bioassay Platform that will be used to determine the potency of current and future products, and to validate the anti-virulence mode of action of candidate products against target pathogens of commercial interest. The collection of analytical and biological assays for the Bioassay Platform will monitor:
1) Virulence and Quorum Sensing Gene Expression changes, in selected pathogens, to the presence of the technology
2) Phenotypic behavioural response of selected pathogen to virulence gene changes
3) In vivo Clinical response to pathogen behaviour changes due to quorum inhibition
$351,595.00
Sep 17, 2019
214090
214090
Acquire equipment to scale-up production capacity and improve productivity
$659,891.00
Sep 16, 2019
For-profit organization
Postbiotic and Proteobiotic development
934635
MicroSintesis is developing novel microbiome solutions to target human and animal disease. We will investigate the use and application of natural probiotic metabolites to modulate the microbiome to improve health and wellness.
$1,472.00
Apr 23, 2019
Through the application of national and local priorities, the CSJ program seeks to provide youth who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills. The CSJ program is delivered by the Department of ESD.
$41,210.00
Apr 1, 2019
For-profit organization
Antibiotic Replacement Project
924891
MicroSintesis will be testing the efficacy of proteobiotics and their ability to reduce Necrotic Enteritis in poultry. A proteobiotic dose response will be compared to a commercial antibiotic used to treat Necrotic Enteritis.
$5.00
Jan 14, 2019
Individual or sole proprietorship
Experience Awards
11020192020Q15599
NSERC’s Experience Awards (previously Industrial Undergraduate Student Research Awards [IUSRA]) offer organizations access to talented natural sciences and engineering undergraduate students for a work term. This cost-shared program allows students to address organization-specific R&D challenges while gaining valuable industrial experience. Experience Awards also let organizations identify potential future full-time employees.
$50,000.00
Jan 2, 2019
For-profit organization
Cell Adhesion
918137
MicroSintesis is a new biotechnology company specializing in the science of proteobiotics; bio-active metabolites produced by probiotics. Using proprietary fermentation and strain selection techniques we are creating a new generation of scientifically advanced probiotics.
$50,000.00
Mar 12, 2018
For-profit organization
Anaerobic Assay Development of Proteobiotics
903230
MicroSintesis is a new biotechnology company specializing in the science of proteobiotics, bio-active metabolites produced by probiotics. Using proprietary fermentation and strain selection techniques, we are creating a new generation of scientifically advanced probiotics.x000D
x000D
With this project, MicroSintesis will expand the commercial application for our technology and evaluate the efficacy of proteobiotics to impact the ability of the anaerobic pathogen, Clostridium perfringens, to cause infection in poultry. To do this, we will develop the anaerobic assays and production methods to support the pathogen's growth/testing with the goal of creating a new platform of products effective against anaerobic pathogens.x000D
x000D
$50,000.00
Feb 28, 2018
$50,000.00
Nov 10, 2017
211178
211178
Hire a clinical program coordinator